Share Price and Basic Stock Data
Last Updated: February 12, 2026, 10:15 pm
| PEG Ratio | 5.14 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
EMS Ltd operates in the Water Supply & Management sector, with a current market capitalization of ₹2,057 Cr and a share price of ₹370. The company reported a significant increase in sales, rising from ₹326 Cr in March 2020 to ₹966 Cr in March 2025, reflecting a compound annual growth rate (CAGR) of approximately 45.5%. Quarterly sales for September 2023 were ₹211 Cr, up from ₹190 Cr in March 2023, indicating a robust quarter-on-quarter growth. This upward trajectory continued into the subsequent quarters, with sales projected to reach ₹270 Cr by March 2025. The company’s operational prowess is highlighted by a reported operating profit margin (OPM) of 21%, which is indicative of efficient cost management relative to industry peers. However, the company’s cash conversion cycle (CCC) stood at 142 days, suggesting a need for further optimization in managing receivables and inventory, which may impact liquidity in the short term.
Profitability and Efficiency Metrics
EMS Ltd’s profitability metrics reveal a healthy financial performance, with a net profit of ₹164 Cr reported for the trailing twelve months (TTM), translating to a net profit margin of 19.02% as of March 2025. The return on equity (ROE) stood at 20.7%, reflecting effective utilization of shareholders’ funds. Additionally, the company achieved a return on capital employed (ROCE) of 26.9%, indicating strong operational efficiency. Operating profit growth from ₹96 Cr in March 2020 to ₹254 Cr in March 2025 showcases the firm’s ability to scale its operations while maintaining profitability. Despite these strengths, the company faced fluctuations in operating profit margins, which dipped to 21% in the most recent reporting period from higher levels in previous years, necessitating a focus on sustaining profitability amidst rising expenses.
Balance Sheet Strength and Financial Ratios
The balance sheet of EMS Ltd reflects a robust financial position, with total assets standing at ₹1,317 Cr as of September 2025, against total liabilities of ₹1,165 Cr. This results in a healthy debt-to-equity ratio of 0.08, underscoring the company’s low reliance on debt for financing operations. The reserves have grown significantly, from ₹218 Cr in March 2020 to ₹986 Cr in September 2025, indicating a strong retained earnings position which can support future growth initiatives. The interest coverage ratio (ICR) is particularly strong at 31.66x, showcasing the company’s ability to meet its interest obligations comfortably. However, with borrowing amounting to ₹165 Cr, the company must manage its debt levels prudently to maintain financial flexibility. The price-to-book value (P/BV) ratio of 3.52x suggests that the market is valuing the company at a premium, reflecting investor confidence in its growth prospects.
Shareholding Pattern and Investor Confidence
As of September 2025, the shareholding pattern of EMS Ltd shows a significant promoter holding of 69.70%, which indicates strong control and alignment of interests with shareholders. The public shareholding has increased to 29.79%, suggesting growing interest from retail investors. However, foreign institutional investors (FIIs) hold a mere 0.15%, while domestic institutional investors (DIIs) account for 0.35%, reflecting limited institutional participation in this stock. The number of shareholders rose to 1,28,706, indicating a broader base of retail investors, which can be seen as a positive sign of market confidence. Nevertheless, the low FII and DII participation may limit liquidity and price discovery in the stock, posing a risk if these investors choose to exit their positions. The increasing public shareholding percentage suggests that the company is attracting retail interest, which can bolster its market reputation.
Outlook, Risks, and Final Insight
Looking ahead, EMS Ltd is well-positioned for growth, given its strong revenue trajectory and solid profitability metrics. However, the company faces several risks, including the potential for rising operational costs, which could pressure profit margins. Additionally, the lengthy cash conversion cycle may pose liquidity challenges, particularly if sales growth does not keep pace with operational expenses. The company’s reliance on domestic markets for its revenue could also be a risk if economic conditions deteriorate. On the other hand, if EMS Ltd manages to streamline its operations effectively and optimize its working capital, it could further enhance its profitability and shareholder value. The significant reserves can provide a cushion for investments in growth initiatives or improvements in operational efficiency. Ultimately, while EMS Ltd showcases a promising outlook, careful attention to cash flow management and cost control will be crucial for sustaining its growth trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| EMS Ltd | 1,944 Cr. | 351 | 714/322 | 11.9 | 187 | 0.43 % | 26.9 % | 20.7 % | 10.0 |
| Industry Average | 1,944.00 Cr | 351.00 | 11.90 | 187.00 | 0.43% | 26.90% | 20.70% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121 | 151 | 190 | 138 | 211 | 200 | 245 | 206 | 233 | 245 | 270 | 239 | 172 |
| Expenses | 78 | 109 | 143 | 106 | 154 | 153 | 178 | 156 | 165 | 174 | 205 | 185 | 136 |
| Operating Profit | 43 | 43 | 48 | 32 | 57 | 47 | 68 | 50 | 69 | 71 | 65 | 54 | 36 |
| OPM % | 36% | 28% | 25% | 23% | 27% | 23% | 28% | 24% | 29% | 29% | 24% | 23% | 21% |
| Other Income | 2 | 1 | 2 | 1 | 8 | 6 | 1 | 2 | 2 | 3 | 2 | 2 | 5 |
| Interest | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 3 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 3 | 3 | 3 | 2 |
| Profit before tax | 43 | 42 | 48 | 31 | 62 | 51 | 64 | 49 | 67 | 70 | 63 | 51 | 36 |
| Tax % | 31% | 28% | 25% | 25% | 26% | 26% | 26% | 25% | 26% | 27% | 25% | 25% | 23% |
| Net Profit | 30 | 30 | 36 | 23 | 45 | 37 | 47 | 37 | 50 | 51 | 47 | 38 | 28 |
| EPS in Rs | 8.15 | 6.72 | 8.53 | 6.68 | 8.94 | 9.09 | 8.39 | 6.82 | 5.09 |
Last Updated: December 27, 2025, 2:38 am
Below is a detailed analysis of the quarterly data for EMS Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 172.00 Cr.. The value appears to be declining and may need further review. It has decreased from 239.00 Cr. (Jun 2025) to 172.00 Cr., marking a decrease of 67.00 Cr..
- For Expenses, as of Sep 2025, the value is 136.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 185.00 Cr. (Jun 2025) to 136.00 Cr., marking a decrease of 49.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 54.00 Cr. (Jun 2025) to 36.00 Cr., marking a decrease of 18.00 Cr..
- For OPM %, as of Sep 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Jun 2025) to 21.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Jun 2025) to 5.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Jun 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Jun 2025) to 36.00 Cr., marking a decrease of 15.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Jun 2025) to 23.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Jun 2025) to 28.00 Cr., marking a decrease of 10.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.09. The value appears to be declining and may need further review. It has decreased from 6.82 (Jun 2025) to 5.09, marking a decrease of 1.73.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:47 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 326 | 331 | 360 | 538 | 793 | 966 | 926 |
| Expenses | 230 | 232 | 247 | 388 | 589 | 712 | 700 |
| Operating Profit | 96 | 99 | 113 | 150 | 204 | 254 | 226 |
| OPM % | 30% | 30% | 31% | 28% | 26% | 26% | 24% |
| Other Income | 7 | 5 | 3 | 5 | 16 | 16 | 13 |
| Interest | 3 | 4 | 6 | 4 | 6 | 11 | 9 |
| Depreciation | 2 | 2 | 3 | 3 | 7 | 10 | 10 |
| Profit before tax | 98 | 98 | 107 | 148 | 207 | 249 | 220 |
| Tax % | 26% | 27% | 27% | 26% | 26% | 26% | |
| Net Profit | 72 | 72 | 79 | 109 | 153 | 184 | 164 |
| EPS in Rs | 27.44 | 33.05 | 29.39 | ||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 7% | 5% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 9.72% | 37.97% | 40.37% | 20.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | 9.72% | 28.25% | 2.39% | -20.11% |
EMS Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: February 1, 2026, 4:45 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 47 | 56 | 56 | 56 |
| Reserves | 218 | 290 | 368 | 444 | 743 | 920 | 986 |
| Borrowings | 16 | 4 | 4 | 45 | 71 | 86 | 165 |
| Other Liabilities | 62 | 73 | 119 | 103 | 101 | 104 | 111 |
| Total Liabilities | 308 | 378 | 503 | 639 | 970 | 1,165 | 1,317 |
| Fixed Assets | 31 | 36 | 51 | 54 | 94 | 96 | 126 |
| CWIP | 0 | 3 | 0 | 4 | -0 | -0 | 37 |
| Investments | 0 | 0 | 1 | 2 | 10 | 18 | 10 |
| Other Assets | 276 | 340 | 451 | 579 | 866 | 1,052 | 1,143 |
| Total Assets | 308 | 378 | 503 | 639 | 970 | 1,165 | 1,317 |
Below is a detailed analysis of the balance sheet data for EMS Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 56.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 56.00 Cr..
- For Reserves, as of Sep 2025, the value is 986.00 Cr.. The value appears strong and on an upward trend. It has increased from 920.00 Cr. (Mar 2025) to 986.00 Cr., marking an increase of 66.00 Cr..
- For Borrowings, as of Sep 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 86.00 Cr. (Mar 2025) to 165.00 Cr., marking an increase of 79.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 111.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 104.00 Cr. (Mar 2025) to 111.00 Cr., marking an increase of 7.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,317.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,165.00 Cr. (Mar 2025) to 1,317.00 Cr., marking an increase of 152.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 96.00 Cr. (Mar 2025) to 126.00 Cr., marking an increase of 30.00 Cr..
- For CWIP, as of Sep 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 37.00 Cr., marking an increase of 37.00 Cr..
- For Investments, as of Sep 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 8.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,143.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,052.00 Cr. (Mar 2025) to 1,143.00 Cr., marking an increase of 91.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,317.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,165.00 Cr. (Mar 2025) to 1,317.00 Cr., marking an increase of 152.00 Cr..
Notably, the Reserves (986.00 Cr.) exceed the Borrowings (165.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | 80.00 | 95.00 | 109.00 | 105.00 | 133.00 | 168.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 44 | 103 | 160 | 84 | 112 | 142 |
| Inventory Days | ||||||
| Days Payable | ||||||
| Cash Conversion Cycle | 44 | 103 | 160 | 84 | 112 | 142 |
| Working Capital Days | 125 | 183 | 219 | 137 | 180 | 187 |
| ROCE % | 37% | 33% | 33% | 29% | 27% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Navi Flexi Cap Fund | 106,000 | 2.13 | 5.6 | 30,000 | 2025-10-17 02:28:48 | 253.33% |
| Navi Aggressive Hybrid Fund | 33,737 | 1.41 | 1.78 | 56,737 | 2025-11-03 11:37:17 | -40.54% |
| Navi Large & Midcap Fund | 10,500 | 0.17 | 0.55 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 33.05 | 29.38 | 23.16 | 67.27 | 61.24 |
| Diluted EPS (Rs.) | 33.05 | 29.38 | 23.16 | 67.27 | 61.24 |
| Cash EPS (Rs.) | 34.83 | 28.67 | 23.88 | 69.32 | 62.68 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 175.70 | 144.16 | 104.86 | 324.36 | 257.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 175.70 | 144.16 | 104.86 | 324.36 | 257.09 |
| Revenue From Operations / Share (Rs.) | 173.93 | 142.86 | 114.50 | 306.26 | 281.45 |
| PBDIT / Share (Rs.) | 48.09 | 39.55 | 33.00 | 98.52 | 88.83 |
| PBIT / Share (Rs.) | 46.35 | 38.37 | 32.28 | 96.37 | 87.36 |
| PBT / Share (Rs.) | 44.84 | 37.24 | 31.46 | 91.48 | 83.57 |
| Net Profit / Share (Rs.) | 33.09 | 27.49 | 23.16 | 67.17 | 61.20 |
| NP After MI And SOA / Share (Rs.) | 33.05 | 27.44 | 22.91 | 66.51 | 61.18 |
| PBDIT Margin (%) | 27.64 | 27.68 | 28.82 | 32.16 | 31.56 |
| PBIT Margin (%) | 26.65 | 26.85 | 28.19 | 31.46 | 31.03 |
| PBT Margin (%) | 25.77 | 26.06 | 27.47 | 29.87 | 29.69 |
| Net Profit Margin (%) | 19.02 | 19.24 | 20.22 | 21.93 | 21.74 |
| NP After MI And SOA Margin (%) | 19.00 | 19.20 | 20.01 | 21.71 | 21.73 |
| Return on Networth / Equity (%) | 18.81 | 19.09 | 21.94 | 20.55 | 23.80 |
| Return on Capital Employeed (%) | 23.98 | 24.18 | 26.92 | 28.74 | 32.87 |
| Return On Assets (%) | 15.75 | 15.70 | 16.78 | 15.55 | 19.00 |
| Long Term Debt / Equity (X) | 0.08 | 0.08 | 0.09 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.08 | 0.08 | 0.09 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.90 | 0.98 | 0.94 | 0.00 | 0.90 |
| Current Ratio (X) | 8.15 | 6.14 | 5.41 | 3.82 | 4.54 |
| Quick Ratio (X) | 7.63 | 5.14 | 4.06 | 3.32 | 4.00 |
| Inventory Turnover Ratio (X) | 14.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 3.02 | 3.64 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 2.87 | 3.49 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 96.98 | 96.36 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 97.13 | 96.51 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 31.66 | 34.95 | 40.38 | 20.15 | 23.44 |
| Interest Coverage Ratio (Post Tax) (X) | 22.79 | 25.29 | 29.34 | 14.74 | 17.15 |
| Enterprise Value (Cr.) | 3358.69 | 2183.92 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 3.48 | 2.75 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 12.58 | 9.94 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 3.55 | 2.81 | 0.00 | 0.00 | 0.00 |
| Retention Ratios (%) | 96.97 | 96.35 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.52 | 2.79 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 3.55 | 2.81 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.05 | 0.06 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for EMS Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 33.05. This value is within the healthy range. It has increased from 29.38 (Mar 24) to 33.05, marking an increase of 3.67.
- For Diluted EPS (Rs.), as of Mar 25, the value is 33.05. This value is within the healthy range. It has increased from 29.38 (Mar 24) to 33.05, marking an increase of 3.67.
- For Cash EPS (Rs.), as of Mar 25, the value is 34.83. This value is within the healthy range. It has increased from 28.67 (Mar 24) to 34.83, marking an increase of 6.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 175.70. It has increased from 144.16 (Mar 24) to 175.70, marking an increase of 31.54.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 175.70. It has increased from 144.16 (Mar 24) to 175.70, marking an increase of 31.54.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 173.93. It has increased from 142.86 (Mar 24) to 173.93, marking an increase of 31.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 48.09. This value is within the healthy range. It has increased from 39.55 (Mar 24) to 48.09, marking an increase of 8.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 46.35. This value is within the healthy range. It has increased from 38.37 (Mar 24) to 46.35, marking an increase of 7.98.
- For PBT / Share (Rs.), as of Mar 25, the value is 44.84. This value is within the healthy range. It has increased from 37.24 (Mar 24) to 44.84, marking an increase of 7.60.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 33.09. This value is within the healthy range. It has increased from 27.49 (Mar 24) to 33.09, marking an increase of 5.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 33.05. This value is within the healthy range. It has increased from 27.44 (Mar 24) to 33.05, marking an increase of 5.61.
- For PBDIT Margin (%), as of Mar 25, the value is 27.64. This value is within the healthy range. It has decreased from 27.68 (Mar 24) to 27.64, marking a decrease of 0.04.
- For PBIT Margin (%), as of Mar 25, the value is 26.65. This value exceeds the healthy maximum of 20. It has decreased from 26.85 (Mar 24) to 26.65, marking a decrease of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 25.77. This value is within the healthy range. It has decreased from 26.06 (Mar 24) to 25.77, marking a decrease of 0.29.
- For Net Profit Margin (%), as of Mar 25, the value is 19.02. This value exceeds the healthy maximum of 10. It has decreased from 19.24 (Mar 24) to 19.02, marking a decrease of 0.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.00. This value is within the healthy range. It has decreased from 19.20 (Mar 24) to 19.00, marking a decrease of 0.20.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.81. This value is within the healthy range. It has decreased from 19.09 (Mar 24) to 18.81, marking a decrease of 0.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.98. This value is within the healthy range. It has decreased from 24.18 (Mar 24) to 23.98, marking a decrease of 0.20.
- For Return On Assets (%), as of Mar 25, the value is 15.75. This value is within the healthy range. It has increased from 15.70 (Mar 24) to 15.75, marking an increase of 0.05.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.98 (Mar 24) to 0.90, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 8.15. This value exceeds the healthy maximum of 3. It has increased from 6.14 (Mar 24) to 8.15, marking an increase of 2.01.
- For Quick Ratio (X), as of Mar 25, the value is 7.63. This value exceeds the healthy maximum of 2. It has increased from 5.14 (Mar 24) to 7.63, marking an increase of 2.49.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.10. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 14.10, marking an increase of 14.10.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.02. This value is below the healthy minimum of 20. It has decreased from 3.64 (Mar 24) to 3.02, marking a decrease of 0.62.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 20. It has decreased from 3.49 (Mar 24) to 2.87, marking a decrease of 0.62.
- For Earning Retention Ratio (%), as of Mar 25, the value is 96.98. This value exceeds the healthy maximum of 70. It has increased from 96.36 (Mar 24) to 96.98, marking an increase of 0.62.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.13. This value exceeds the healthy maximum of 70. It has increased from 96.51 (Mar 24) to 97.13, marking an increase of 0.62.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 31.66. This value is within the healthy range. It has decreased from 34.95 (Mar 24) to 31.66, marking a decrease of 3.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 22.79. This value is within the healthy range. It has decreased from 25.29 (Mar 24) to 22.79, marking a decrease of 2.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,358.69. It has increased from 2,183.92 (Mar 24) to 3,358.69, marking an increase of 1,174.77.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.48. This value exceeds the healthy maximum of 3. It has increased from 2.75 (Mar 24) to 3.48, marking an increase of 0.73.
- For EV / EBITDA (X), as of Mar 25, the value is 12.58. This value is within the healthy range. It has increased from 9.94 (Mar 24) to 12.58, marking an increase of 2.64.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.55. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.55, marking an increase of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 96.97. This value exceeds the healthy maximum of 70. It has increased from 96.35 (Mar 24) to 96.97, marking an increase of 0.62.
- For Price / BV (X), as of Mar 25, the value is 3.52. This value exceeds the healthy maximum of 3. It has increased from 2.79 (Mar 24) to 3.52, marking an increase of 0.73.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.55. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.55, marking an increase of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in EMS Ltd:
- Net Profit Margin: 19.02%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.98% (Industry Average ROCE: 26.9%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.81% (Industry Average ROE: 20.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 22.79
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 7.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.9 (Industry average Stock P/E: 11.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.02%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Water Supply & Management | 701, DLF Tower A, Jasola, New Delhi Delhi 110025 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramveer Singh | Chairman & Director |
| Mr. Ashish Tomar | Managing Director & CFO |
| Mrs. Kritika Tomar | Whole Time Director |
| Ms. Swati Jain | Ind. Non-Executive Director |
| Mr. Mukesh Garg | Ind. Non-Executive Director |
| Mrs. Chetna | Ind. Non-Executive Director |
| Mr. Achal Kapoor | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of EMS Ltd?
EMS Ltd's intrinsic value (as of 12 February 2026) is ₹378.66 which is 7.88% higher the current market price of ₹351.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,944 Cr. market cap, FY2025-2026 high/low of ₹714/322, reserves of ₹986 Cr, and liabilities of ₹1,317 Cr.
What is the Market Cap of EMS Ltd?
The Market Cap of EMS Ltd is 1,944 Cr..
What is the current Stock Price of EMS Ltd as on 12 February 2026?
The current stock price of EMS Ltd as on 12 February 2026 is ₹351.
What is the High / Low of EMS Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of EMS Ltd stocks is ₹714/322.
What is the Stock P/E of EMS Ltd?
The Stock P/E of EMS Ltd is 11.9.
What is the Book Value of EMS Ltd?
The Book Value of EMS Ltd is 187.
What is the Dividend Yield of EMS Ltd?
The Dividend Yield of EMS Ltd is 0.43 %.
What is the ROCE of EMS Ltd?
The ROCE of EMS Ltd is 26.9 %.
What is the ROE of EMS Ltd?
The ROE of EMS Ltd is 20.7 %.
What is the Face Value of EMS Ltd?
The Face Value of EMS Ltd is 10.0.